| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1037451733 |
| P356 | DOI | 10.2165/00002018-200326100-00002 |
| P698 | PubMed publication ID | 12862503 |
| P2093 | author name string | Xin Chen | |
| Yu Zong Chen | |||
| Chun Wei Yap | |||
| Li Zhi Sun | |||
| Lian Yi Han | |||
| Zhi Liang Ji | |||
| P2860 | cites work | The Protein Data Bank | Q24515306 |
| Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach | Q28191975 | ||
| The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. | Q29547492 | ||
| Beyond complete genomes: from sequence to structure and function | Q32053512 | ||
| Immunotoxic side-effects of drug therapy. | Q33397114 | ||
| Microarrays and toxicology: the advent of toxicogenomics | Q33594789 | ||
| DNA chips: promising toys have become powerful tools | Q33632939 | ||
| Pharmacodynamics and toxicodynamics of drug action: signaling in cell survival and cell death | Q33682659 | ||
| The neurochemistry of phenylketonuria. | Q33922473 | ||
| Mitochondrial targets of drug toxicity | Q33932157 | ||
| Key challenges for toxicologists in the 21st century | Q33950216 | ||
| PubMed: bridging the information gap. | Q33955736 | ||
| Advances in pharmacogenetics and pharmacogenomics | Q34024117 | ||
| Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity | Q34088814 | ||
| Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery? | Q34206002 | ||
| Genetic susceptibility to adverse drug reactions | Q34275394 | ||
| Galactosemia: screening and diagnosis | Q37547519 | ||
| Prostaglandins and the mechanism of action of anti-inflammatory drugs | Q40209463 | ||
| Protein targets of xenobiotic reactive intermediates | Q41455721 | ||
| Glutathione peroxidase and catalase modulate the genotoxicity of arsenite | Q42548545 | ||
| Mechanism for the emetic side effect of xanthine bronchodilators | Q46612220 | ||
| Genomics and medicine. Dissecting human disease in the postgenomic era. | Q46710203 | ||
| Integrating computer prediction systems with in vitro methods towards a better understanding of toxicology | Q74449354 | ||
| The pharmacology and toxicology of polyphenolic-glutathione conjugates | Q74578165 | ||
| Proteomics: translating genomics into products? | Q74649961 | ||
| 100,000 protein structures for the biologist | Q77659489 | ||
| P433 | issue | 10 | |
| P921 | main subject | database | Q8513 |
| P304 | page(s) | 685-690 | |
| P577 | publication date | 2003-01-01 | |
| P1433 | published in | Drug Safety | Q15724462 |
| P1476 | title | Drug Adverse Reaction Target Database (DART) : proteins related to adverse drug reactions | |
| P478 | volume | 26 |
| Q92107770 | A comprehensive review of computational techniques for the prediction of drug side effects |
| Q47156223 | ADReCS-Target: target profiles for aiding drug safety research and application. |
| Q38088336 | Building a drug-target network and its applications |
| Q28260664 | Chemogenomics: an emerging strategy for rapid target and drug discovery |
| Q58576167 | Comparison of Quantitative and Qualitative (Q)SAR Models Created for the Prediction of K and IC Values of Antitarget Inhibitors |
| Q34066066 | Computational methods for early predictive safety assessment from biological and chemical data |
| Q56977996 | Computational toxicology: an overview of the sources of data and of modelling methods |
| Q55341853 | Docking-based inverse virtual screening: methods, applications, and challenges. |
| Q28477582 | Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study |
| Q27335598 | Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome |
| Q28473107 | Identifying unexpected therapeutic targets via chemical-protein interactome |
| Q93061511 | In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
| Q33569566 | Kinase inhibition-related adverse events predicted from in vitro kinome and clinical trial data |
| Q37387324 | Large-scale identification of adverse drug reaction-related proteins through a random walk model |
| Q36059863 | Large-scale prediction and testing of drug activity on side-effect targets |
| Q36287437 | Multi-algorithm and multi-model based drug target prediction and web server |
| Q40175868 | Network characteristic analysis of ADR-related proteins and identification of ADR-ADR associations. |
| Q35567962 | PharmGED: Pharmacogenetic Effect Database |
| Q36917998 | SM-TF: A structural database of small molecule-transcription factor complexes |
| Q30488528 | SePreSA: a server for the prediction of populations susceptible to serious adverse drug reactions implementing the methodology of a chemical-protein interactome |
Search more.